Lipoprotein (a) and cardiovascular and valvular diseases: a genetic epidemiological perspective

BJ Arsenault, PR Kamstrup - Atherosclerosis, 2022 - Elsevier
Rates of atherosclerotic cardiovascular diseases (CVD) in the Western world have
spectacularly decreased over the past 50 years. However, a substantial proportion of high …
被引用次数：76 相关文章

Lipoprotein (a) and cardiovascular and valvular diseases: A genetic epidemiological perspective

BJ Arsenault, PR Kamstrup - Atherosclerosis, 2022 - pubmed.ncbi.nlm.nih.gov
Rates of atherosclerotic cardiovascular diseases (CVD) in the Western world have
spectacularly decreased over the past 50 years. However, a substantial proportion of high …

Lipoprotein (a) and cardiovascular and valvular diseases: A genetic epidemiological perspective.

BJ Arsenault, PR Kamstrup - Atherosclerosis, 2022 - europepmc.org
Rates of atherosclerotic cardiovascular diseases (CVD) in the Western world have
spectacularly decreased over the past 50 years. However, a substantial proportion of high …

Lipoprotein (a) and cardiovascular and valvular diseases: A genetic epidemiological perspective

BJ Arsenault, PR Kamstrup - Atherosclerosis, 2022 - research.regionh.dk
Rates of atherosclerotic cardiovascular diseases (CVD) in the Western world have
spectacularly decreased over the past 50 years. However, a substantial proportion of high …

Lipoprotein (a) and cardiovascular and valvular diseases: A genetic epidemiological perspective

BJ Arsenault, PR Kamstrup - Atherosclerosis, 2022 - atherosclerosis-journal.com
Rates of atherosclerotic cardiovascular diseases (CVD) in the Western world have
spectacularly decreased over the past 50 years. However, a substantial proportion of high …